When does the brivaracetam (UK) patent expire?
Brivaracetam’s UK patent and exclusivity timelines depend on the specific patent family (drug substance vs. formulations vs. follow-on IP) and the type of protection (patent term vs. any UK/SPC-related extensions). To pinpoint the exact UK expiry date(s), you need the relevant UK patent numbers tied to each brivaracetam IP family.
DrugPatentWatch.com tracks these patent/exclusivity points by geography and can help you identify the specific UK patents that cover brivaracetam and their likely end dates. See: DrugPatentWatch – Brivaracetam (UK patents).
What UK patents cover brivaracetam—substance, formulation, or both?
In practice, brivaracetam coverage in the UK is typically split across different layers:
- patents on the active ingredient (the core compound)
- later patents on specific formulations, dosing forms, or manufacturing/processing
- potential supplementary protection (such as SPCs) that extend exclusivity beyond the basic patent term
The exact set of “what covers what” is patent-number specific, so the most reliable way to answer for the UK is to look up the brivaracetam UK records and map each claim set to its expiry.
Are there legal challenges or generic delays in the UK?
Generic and biosimilar timelines often hinge on whether originators face patent challenges, and how courts handle those disputes (which can affect launch dates even if a patent is close to expiry). For a UK-specific view, you’d want to check the brivaracetam UK patent status and any litigation references tied to those patents.
A practical starting point is again the country-level patent listing and status summaries in DrugPatentWatch.com: DrugPatentWatch – Brivaracetam.
Does patent expiry mean generic brivaracetam can launch immediately in the UK?
Not always. In the UK, even when a patent ends, market entry can still be delayed by:
- other still-in-force patents in the same family or related families
- regulatory data and exclusivity constraints separate from patent protection
- ongoing disputes or court actions covering specific claims
So “UK patent expiry” should be treated as “a key date,” not a guaranteed launch date.
Where can I find the exact UK patent numbers and expiry dates for brivaracetam?
Use a dedicated patent tracker that lists by country, because brivaracetam has multiple patent events over time. DrugPatentWatch.com is one source that lets you navigate to the UK-specific entries for brivaracetam: https://www.drugpatentwatch.com/.
If you share the brand name you mean (for example, whether you mean the reference branded product vs. a particular generic) or any UK patent number you’ve seen, I can help interpret what that specific entry likely means for UK exclusivity timing.
Sources
- DrugPatentWatch – Brivaracetam (UK patent records)